Company: APXIF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026189
Chunk: 246

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 246
---
 Sponsors are likely to make a substantial profit on its investment in us in the event we consummate an initial business combination,
even if the business combination causes the trading price of our ordinary shares to decline materially. 

While we offered our units at an offering price
of $10.00 per unit and the amount in the Trust Account is anticipated to be $12.05 per public share, implying an initial value of $12.05
per public share, the APx Sponsor paid only a nominal aggregate purchase price of $25,000 for the founder shares, or approximately $0.006
per share. As a result, the value of your public shares may be significantly diluted in the event we consummate an initial business combination.
APx Sponsor invested an aggregate of $8,975,000 in us in connection with the IPO, comprised of the $25,000 purchase price for the founder
shares and the $8,950,000 purchase price for the private placement warrants. As a result, even if the trading price of our ordinary shares
significantly declines, our Sponsors will stand to make significant profit on its investment in us. In addition, our Sponsors could potentially
recoup its entire investment in us even if the trading price of our ordinary shares is less than $1.00 per share and even if the private
placement warrants are worthless. As a result, our Sponsors are likely to make a substantial profit on their respective investment in
us even if we select and consummate an initial business combination that causes the trading price of our ordinary shares to decline, while
our public shareholders who purchased their units in the IPO could lose significant value in their public shares. Our sponsor may therefore
be economically incentivized to consummate an initial business combination with a riskier, weaker performing or less established target
business than would be the case if our sponsor had paid the same per share price for the founder shares as our public shareholders paid
for their public shares.

19

Because we must furnish our shareholders with target business
financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective
target businesses. 

The federal proxy rules require that the proxy
statement with respect to the vote on an initial business combination include historical and pro forma financial statement disclosure.
We will include the same financial statement disclosure in connection with our tender offer documents, whether or not they are required
under the tender offer rules. These financial statements may be required to be prepared in accordance with, or be reconc